24 May 2013
Keywords: fda, adds, new, ae, data, label, gilead
Article | 13 March 2006
The USA's Gilead Sciences says that the Food and Drug Administration has granted traditional approval status to its once-daily antiretroviral
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 2006
23 May 2013
© 2013 thepharmaletter.com